Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2026 Filed Feb 19, 2026 21:18 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Tax withholdingCommon Stock | 2,964 | $483.75 | $1,433,835.00 |
DisclosureSEC source: 0000875320-26-000092 · wk-form4_1771535929.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,344 Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 21:28 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 368 | $473.68 | $174,314.24 |
DisclosureSEC source: 0000875320-26-000098 · wk-form4_1771536504.xml · nonDerivative · entry 4 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,650 F2 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:03 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
SaleCommon Stock | 1,557 | $489.46 | $762,089.22 |
DisclosureSEC source: 0000875320-26-000080 · wk-form4_1771535003.xml · nonDerivative · entry 3 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,388 F2 · kind: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2025. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:03 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 598 | $483.75 | $289,282.50 |
DisclosureSEC source: 0000875320-26-000080 · wk-form4_1771535003.xml · nonDerivative · entry 2 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,945 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:03 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
GrantCommon Stock | 1,809 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000080 · wk-form4_1771535003.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,543 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:06 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
SaleCommon Stock | 2,031 | $489.46 | $994,093.26 |
DisclosureSEC source: 0000875320-26-000082 · wk-form4_1771535181.xml · nonDerivative · entry 3 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,544 F2 · kind: Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:06 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
Tax withholdingCommon Stock | 1,530 | $483.75 | $740,137.50 |
DisclosureSEC source: 0000875320-26-000082 · wk-form4_1771535181.xml · nonDerivative · entry 2 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,575 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:06 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
GrantCommon Stock | 4,962 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000082 · wk-form4_1771535181.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,105 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:08 UTC |
Biller JonathanEVP and Chief Legal Officer
|
SaleCommon Stock | 2,476 | $489.46 | $1,211,902.96 |
DisclosureSEC source: 0000875320-26-000084 · wk-form4_1771535316.xml · nonDerivative · entry 3 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,992 F2 · kind: Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:08 UTC |
Biller JonathanEVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 1,505 | $483.75 | $728,043.75 |
DisclosureSEC source: 0000875320-26-000084 · wk-form4_1771535316.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,468 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:08 UTC |
Biller JonathanEVP and Chief Legal Officer
|
GrantCommon Stock | 4,135 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000084 · wk-form4_1771535316.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,973 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:10 UTC |
Bozic CarmenEVP and CMO
|
Tax withholdingCommon Stock | 1,912 | $483.75 | $924,930.00 |
DisclosureSEC source: 0000875320-26-000086 · wk-form4_1771535456.xml · nonDerivative · entry 2 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,516 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:10 UTC |
Bozic CarmenEVP and CMO
|
GrantCommon Stock | 5,375 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000086 · wk-form4_1771535456.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,428 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:12 UTC |
Bunnage Mark E.EVP, Chief Scientific Officer
|
SaleCommon Stock | 2,437 | $489.46 | $1,192,814.02 |
DisclosureSEC source: 0000875320-26-000088 · wk-form4_1771535561.xml · nonDerivative · entry 3 Bunnage Mark E. · CIK 0002100735 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,668 F2 · kind: Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:12 UTC |
Bunnage Mark E.EVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 1,110 | $483.75 | $536,962.50 |
DisclosureSEC source: 0000875320-26-000088 · wk-form4_1771535561.xml · nonDerivative · entry 2 Bunnage Mark E. · CIK 0002100735 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,105 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:12 UTC |
Bunnage Mark E.EVP, Chief Scientific Officer
|
GrantCommon Stock | 2,584 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000088 · wk-form4_1771535561.xml · nonDerivative · entry 1 Bunnage Mark E. · CIK 0002100735 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,215 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:16 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Tax withholdingCommon Stock | 6,554 | $483.75 | $3,170,497.50 |
DisclosureSEC source: 0000875320-26-000090 · wk-form4_1771535794.xml · nonDerivative · entry 2 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,259 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:16 UTC |
Kewalramani ReshmaDirector · CEO & President
|
GrantCommon Stock | 16,326 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000090 · wk-form4_1771535794.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,813 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:18 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
GrantCommon Stock | 8,269 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000092 · wk-form4_1771535929.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,308 F1 · shares: Restricted stock unit award that fully vested upon grant. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:21 UTC |
McKechnie DuncanEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,148 | $483.75 | $555,345.00 |
DisclosureSEC source: 0000875320-26-000094 · wk-form4_1771536070.xml · nonDerivative · entry 2 McKechnie Duncan · CIK 0002062139 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,342 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:21 UTC |
McKechnie DuncanEVP, Chief Commercial Officer
|
GrantCommon Stock | 4,962 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000094 · wk-form4_1771536070.xml · nonDerivative · entry 1 McKechnie Duncan · CIK 0002062139 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,490 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:24 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
Tax withholdingCommon Stock | 2,140 | $483.75 | $1,035,225.00 |
DisclosureSEC source: 0000875320-26-000096 · wk-form4_1771536296.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,042 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:24 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
GrantCommon Stock | 5,789 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000096 · wk-form4_1771536296.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,182 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:28 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 609 | $489.46 | $298,081.14 |
DisclosureSEC source: 0000875320-26-000098 · wk-form4_1771536504.xml · nonDerivative · entry 3 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,018 F2 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:28 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
Tax withholdingCommon Stock | 2,294 | $483.75 | $1,109,722.50 |
DisclosureSEC source: 0000875320-26-000098 · wk-form4_1771536504.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,627 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:28 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
GrantCommon Stock | 5,789 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000098 · wk-form4_1771536504.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,921 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:30 UTC |
WAGNER CHARLES F JREVP, CO & FO
|
Tax withholdingCommon Stock | 2,294 | $483.75 | $1,109,722.50 |
DisclosureSEC source: 0000875320-26-000100 · wk-form4_1771536607.xml · nonDerivative · entry 2 WAGNER CHARLES F JR · CIK 0001223348 · EVP, CO & FO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,786 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:30 UTC |
WAGNER CHARLES F JREVP, CO & FO
|
GrantCommon Stock | 7,365 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000100 · wk-form4_1771536607.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP, CO & FO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,080 F1 · shares: Restricted stock unit award that vests in installments beginning on February 20, 2027. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:17 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,393 | $487.76 | $679,449.68 |
DisclosureSEC source: 0000875320-26-000058 · wk-form4_1771449464.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,734 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:19 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
Tax withholdingCommon Stock | 1,903 | $487.76 | $928,207.28 |
DisclosureSEC source: 0000875320-26-000060 · wk-form4_1771449589.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,143 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:23 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 266 | $500.00 | $133,000.00 |
DisclosureSEC source: 0000875320-26-000062 · wk-form4_1771449836.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,299 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:26 UTC |
Biller JonathanEVP and Chief Legal Officer
|
SaleCommon Stock | 988 | $499.00 | $493,012.00 |
DisclosureSEC source: 0000875320-26-000064 · wk-form4_1771449971.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,838 F1 · kind: Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:26 UTC |
Biller JonathanEVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 2,993 | $487.76 | $1,459,865.68 |
DisclosureSEC source: 0000875320-26-000064 · wk-form4_1771449971.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,826 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:28 UTC |
Bozic CarmenEVP and CMO
|
Tax withholdingCommon Stock | 3,804 | $487.76 | $1,855,439.04 |
DisclosureSEC source: 0000875320-26-000066 · wk-form4_1771450120.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,053 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:32 UTC |
Bunnage Mark E.EVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 2,283 | $487.76 | $1,113,556.08 |
DisclosureSEC source: 0000875320-26-000068 · wk-form4_1771450339.xml · nonDerivative · entry 1 Bunnage Mark E. · CIK 0002100735 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,631 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:35 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Tax withholdingCommon Stock | 13,041 | $487.76 | $6,360,878.16 |
DisclosureSEC source: 0000875320-26-000070 · wk-form4_1771450516.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,487 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:37 UTC |
McKechnie DuncanEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 2,283 | $487.76 | $1,113,556.08 |
DisclosureSEC source: 0000875320-26-000072 · wk-form4_1771450668.xml · nonDerivative · entry 1 McKechnie Duncan · CIK 0002062139 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,528 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:39 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
Tax withholdingCommon Stock | 3,548 | $487.76 | $1,730,572.48 |
DisclosureSEC source: 0000875320-26-000074 · wk-form4_1771450792.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,393 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:43 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 1,500 | $499.99 | $749,985.00 |
DisclosureSEC source: 0000875320-26-000076 · wk-form4_1771451036.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,132 F1 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025. F2 · price: Open market sales reported on this line occurred at a weighted average price of $499.99 (range $499.99 to $500.04). F3 · price: Dr. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:43 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
Tax withholdingCommon Stock | 3,804 | $487.76 | $1,855,439.04 |
DisclosureSEC source: 0000875320-26-000076 · wk-form4_1771451036.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,632 Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:47 UTC |
WAGNER CHARLES F JREVP, CO & FO
|
Tax withholdingCommon Stock | 4,565 | $487.76 | $2,226,624.40 |
DisclosureSEC source: 0000875320-26-000078 · wk-form4_1771451250.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP, CO & FO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,715 Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:47 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
SaleCommon Stock | 1,376 | $460.43 | $633,551.68 |
DisclosureSEC source: 0000875320-26-000036 · wk-form4_1770932861.xml · nonDerivative · entry 2 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,127 F1 · kind: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2025. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:50 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
SaleCommon Stock | 1,751 | $460.43 | $806,212.93 |
DisclosureSEC source: 0000875320-26-000038 · wk-form4_1770933003.xml · nonDerivative · entry 2 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,046 F1 · kind: Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:52 UTC |
Biller JonathanEVP and Chief Legal Officer
|
SaleCommon Stock | 1,925 | $460.43 | $886,327.75 |
DisclosureSEC source: 0000875320-26-000040 · wk-form4_1770933137.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,819 F1 · kind: Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:56 UTC |
Bunnage Mark E.EVP, Chief Scientific Officer
|
SaleCommon Stock | 2,021 | $460.43 | $930,529.03 |
DisclosureSEC source: 0000875320-26-000044 · wk-form4_1770933367.xml · nonDerivative · entry 2 Bunnage Mark E. · CIK 0002100735 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,914 F1 · kind: Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 22:08 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 466 | $460.43 | $214,560.38 |
DisclosureSEC source: 0000875320-26-000052 · wk-form4_1770934130.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,436 F1 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:47 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 592 | $468.41 | $277,298.72 |
DisclosureSEC source: 0000875320-26-000036 · wk-form4_1770932861.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,503 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:50 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
Tax withholdingCommon Stock | 872 | $468.41 | $408,453.52 |
DisclosureSEC source: 0000875320-26-000038 · wk-form4_1770933003.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,797 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:52 UTC |
Biller JonathanEVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 1,630 | $468.41 | $763,508.30 |
DisclosureSEC source: 0000875320-26-000040 · wk-form4_1770933137.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,744 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:53 UTC |
Bozic CarmenEVP and CMO
|
Tax withholdingCommon Stock | 2,145 | $468.41 | $1,004,739.45 |
DisclosureSEC source: 0000875320-26-000042 · wk-form4_1770933202.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,857 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.